Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement

Mehmet Cilingiroglu,Ibrahim Halil Inanc
DOI: https://doi.org/10.1002/ccd.31252
IF: 2.3
2024-10-01
Catheterization and Cardiovascular Interventions
Abstract:Key points Transcatheter aortic valve replacement (TAVR) is now the standard of care for patients with severe symptomatic aortic stenosis (AS). New conduction defects remain a challenge following TAVR in patients requiring permanent pacemaker implantation (PPI). CMRI identified myocardial fibrosis (MF) with an increased extracellular volume (ECV) is a new predictor for these conduction defects following TAVR.
cardiac & cardiovascular systems
What problem does this paper attempt to address?